857410P
IG7
Manufacturer: Sigma Aldrich
CAS Number: 2132345-13-0
Synonym(S): N-((2S,3R)-3-hydroxy-1-oxo-1-(tridecylamino)butan-2-yl)-5-methoxy-1H-indole-2-carboxamide
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 1 MG | 857410P-1-MG | In Stock | ₹ 19,950.48 |
| 5 MG | 857410P-5-MG | In Stock | ₹ 59,829.78 |
857410P - 1 MG
In Stock
Quantity
1
Base Price: ₹ 19,950.48
GST (18%): ₹ 3,591.086
Total Price: ₹ 23,541.566
Assay
99% (TLC)
form
powder
packaging
pkg of 1 × 1 mg (857410P-5mg)pkg of 1 × 5 mg (857410P-5mg)
manufacturer/tradename
Avanti Polar Lipids
lipid type
bioactive lipids
shipped in
dry ice
storage temp.
−20°C
SMILES string
C[C@@H](O)[C@H](NC(C(N1)=CC2=C1C=CC(OC)=C2)=O)C(NCCCCCCCCCCCCC)=O
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | 2132345-13-0 | N-((2S,3R)-3-hydroxy-1-oxo-1-(tridecylamino)butan-2-yl)-5-methoxy-1H-indole-2-carboxamide | A2B Chem | ₹ 82,907.64 - ₹ 1,66,071.96 |
Description
- General description: IG7 is a ceramide analog.[1]
- Biochem/physiol Actions: IG7 is potent in enhancing Fas ligand (FasL) induced apoptosis in colon carcinoma cells SW480 and RKO. IG7 enhances FasL mediated phosphorylation of p38 and janus kinase (JNK). IG7 enhances nuclear factor-kappa B (NF-κB) activation by FasL. IG7 exhibits low toxicity.[1]
- Packaging: 5ML Glass Amber Screw Cap Vial (857410P-1MG)
SAFETY INFORMATION
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
Assay: 99% (TLC)
form: powder
packaging: pkg of 1 × 1 mg (857410P-5mg)pkg of 1 × 5 mg (857410P-5mg)
manufacturer/tradename: Avanti Polar Lipids
lipid type: bioactive lipids
shipped in: dry ice
storage temp.: −20°C
SMILES string: C[C@@H](O)[C@H](NC(C(N1)=CC2=C1C=CC(OC)=C2)=O)C(NCCCCCCCCCCCCC)=O
Assay:
99% (TLC)
form:
powder
packaging:
pkg of 1 × 1 mg (857410P-5mg)pkg of 1 × 5 mg (857410P-5mg)
manufacturer/tradename:
Avanti Polar Lipids
lipid type:
bioactive lipids
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
C[C@@H](O)[C@H](NC(C(N1)=CC2=C1C=CC(OC)=C2)=O)C(NCCCCCCCCCCCCC)=O
Assay: 99% (TLC)
form: powder
packaging: pkg of 1 × 1 mg (857412P-1mg)pkg of 1 × 5 mg (857412P-5mg)
manufacturer/tradename: Avanti Polar Lipids
lipid type: bioactive lipids
shipped in: dry ice
storage temp.: −20°C
SMILES string: C[C@@H](O)[C@H](NC(C(N1)=CC2=C1C=CC=C2OC)=O)C(NCCCCCCCCCCCCC)=O
Assay:
99% (TLC)
form:
powder
packaging:
pkg of 1 × 1 mg (857412P-1mg)pkg of 1 × 5 mg (857412P-5mg)
manufacturer/tradename:
Avanti Polar Lipids
lipid type:
bioactive lipids
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
C[C@@H](O)[C@H](NC(C(N1)=CC2=C1C=CC=C2OC)=O)C(NCCCCCCCCCCCCC)=O
Assay: 99%
form: powder
packaging: __
manufacturer/tradename: __
lipid type: __
shipped in: __
storage temp.: __
SMILES string: O.O.O.C[C@](N)(Cc1ccc(O)c(O)c1)C(O)=O.C[C@](N)(Cc2ccc(O)c(O)c2)C(O)=O
Assay:
99%
form:
powder
packaging:
__
manufacturer/tradename:
__
lipid type:
__
shipped in:
__
storage temp.:
__
SMILES string:
O.O.O.C[C@](N)(Cc1ccc(O)c(O)c1)C(O)=O.C[C@](N)(Cc2ccc(O)c(O)c2)C(O)=O
Assay: >90% (contains dimer, trimer, tetramer, TLC)
form: methylene chloride solution
packaging: pkg of 1 × 1 mL (857458M-1mg)
manufacturer/tradename: Avanti Polar Lipids 857458M
lipid type: sphingolipids
shipped in: dry ice
storage temp.: −20°C
SMILES string: CCCCCCCCCCCCCCCC([H])=O
Assay:
>90% (contains dimer, trimer, tetramer, TLC)
form:
methylene chloride solution
packaging:
pkg of 1 × 1 mL (857458M-1mg)
manufacturer/tradename:
Avanti Polar Lipids 857458M
lipid type:
sphingolipids
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
CCCCCCCCCCCCCCCC([H])=O